
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-04-01-2015
- Volume 11
- Issue 4
TraceLink Joins PBOA
As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.
The Pharma & Biopharma Outsourcing Association (PBOA) announced that TraceLink has joined the PBOA as an affiliate member. Affiliate companies provide services and goods that benefit both the PBOA's members and their client companies.
"We're happy to have TraceLink aboard as an affiliate member of the Pharma & Biopharma Outsourcing Association," said Gil Roth, president of the PBOA. "As the CMO/CDMO sector has grown in importance and new serialization regulations roll out in different countries, it's critical that our member companies stay on top of the technologies and services available to assure the safety of the drug supply chain. Bringing TraceLink into the conversation with CMOs will only help advance that cause."
"TraceLink is very excited to join the Pharma & Biopharma Outsourcing Association," said Brian Daleiden, vice president of industry marketing at TraceLink. "The CMO/CDMO sector has become a strategically important part of the life sciences supply network. As a result, outsourced supply partners now face significant challenges in meeting diverse pharmaceutical customer requirements, ensuring quality and performance in external supply operations and preparing for continuously evolving global serialization regulations. We’re pleased to work with PBOA and its membership to develop solutions for these key issues."
PBOA is a nonprofit trade association dedicated to advancing the regulatory, legislative and general business interests of contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs).
The TraceLink Life Sciences Cloud is used by businesses to meet strategic goals in ensuring global track-and-trace compliance, fighting drug counterfeiting, improving delivery, protecting product quality, and reducing operational cost, the company reports.
Source:
Articles in this issue
over 10 years ago
Xcelience Receives DEA Approval for Schedule I Drug Productsover 10 years ago
Standard for Excipient GMPs Reflects Industry Consensusover 10 years ago
Serialization Success Depends on Integrated Equipment and Systemsover 10 years ago
Risk-based Strategies to Prevent Drug Shortagesover 10 years ago
Shifting Biopharma Strategies Shape Outsourcing Marketover 10 years ago
Temperature-controlled Logistics Address Cold-Chain Challengesover 10 years ago
Who Will Staff Expanding CMO Operations?over 10 years ago
Kemwell’s Bangalore Facility Completes Successful FDA Inspectionover 10 years ago
Recipharm Delivers Serialization Solutions for Abbott in Koreaover 10 years ago
Laurus Synthesis Launches New Facility in Woburn, MANewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





